Publications

Search/Filter
  • Trump Administration Gives Mixed Signals on Marijuana Market

    Published November 26, 2025
    Publication -
    The Trump administration has stalled in its effort to determine whether to reclassify marijuana from a Schedule I to a Schedule III drug, a new filing by the Drug Enforcement Administration (DEA) in an administrative law hearing acknowledges. “This doesn’t constitute a new delay of rescheduling’s consideration, which has been stalled out for months after […]
  • FDA Approves New Generic Abortion Pills

    Published November 25, 2025
    Publication -
    The Food and Drug Administration (FDA) approved a generic version of the abortion pill mifepristone in October, making chemical abortion more affordable and accessible to pregnant women who wish to terminate the lives of their unborn children. Mifepristone is used in two-thirds of American abortions, according to the pro-abortion Guttmacher Institute. Republicans such as Sen. […]
  • Costco to Sell Ozempic, Wegovy at Almost Half Current Price

    Published November 24, 2025
    Publication -
    The company that sells Ozempic and Wegovy, drugs known for promoting easy weight loss, is now selling the products at Costco. Novo Nordisk, which manufactures the injectable pen semaglutide drugs for type 2 diabetes and weight loss, said in October it is making the prescription drugs available at Costco pharmacies for $499 for a four-week […]
  • Florida Becomes First State to End Vaccine Mandates

    Published November 21, 2025
    Publication -
    Florida Surgeon General Joseph Ladapo, M.D., and Gov. Ron DeSantis are working with the legislature to end all vaccine mandates for schoolchildren in the state. The two leaders announced their decision at a September 3, 2025, news conference. “The Florida Dept. of Health, in partnership with the governor, is going to be working to end […]
  • Merck Leaves UK Over Fears of Drug Price Controls

    Published November 19, 2025
    Publication -
    Pharmaceutical giant Merck announced the cancellation of a planned $1.3 billion research center in London and the termination of all research and development activities in the United Kingdom (UK). The company said on September 10 its decision “reflects the challenges of the UK not making meaningful progress addressing the lack of investment in the life-science […]
  • Research & Commentary: Right to Try Individualized Investigational Treatments Is the Future of Health Care in the States

    Published November 14, 2025
    Publication -
    Research and Commentaries -
    As 2026 approaches, now is the time to reflect on the victories from the year and the lessons to be taken moving forward. Right to try legislation is at the front of the list when it comes to free market health care solutions. While federal right to try legislation was signed into law on May 30, […]
  • Trump, Drug Companies Make Deal on Discounted Drugs Through Trump Rx

    Published November 12, 2025
    Publication -
    Consumers will be able to buy discounted brand-name drugs through a government direct sales exchange called Trump Rx, starting in early 2026. On October 16, the Trump team worked out an agreement with a drug maker to directly sell fertility drugs at a deep discount to lower the cost of in vitro fertilization treatments (see […]
  • Democrats Fight to Extend Obamacare’s Costly Middle-Class Subsidies – Commentary

    Published November 5, 2025
    Publication -
    Democrats in Congress have been desperately trying to keep Obamacare on life support. A recent scare tactic is from the Kaiser Family Foundation (KFF), which estimates Obamacare premiums will rise 114 percent without extending the so-called enhanced subsidies. “In 2021, the American Rescue Plan Act, a pandemic relief law, temporarily increased the amount of the […]
  • White House Announces Policies to Expand IVF, Fertility Treatment

    Published October 29, 2025
    Publication -
    The White House announced two initiatives it claims will significantly reduce the costs of in vitro fertilization (IVF). On October 16, President Donald Trump announced drugmaker EMD Serono would offer its fertility drug GONAL-F at a 796 percent discount or more, in line with the lowest price paid by other developed nations, known as the […]
  • Massive Fraud Found in Minnesota Medicaid Housing Assistance Program – Commentary

    Published October 24, 2025
    Publication -
    “Nonmedical social determinants of health” is a fancy way of saying external conditions can affect people’s well-being. Being homeless is not terribly conducive to good health, and the stress of not having access to affordable housing can worsen an individual’s mental health. Under that premise, numerous states have been diverting Medicaid funding to housing assistance. In 2024, […]
  • Minnesota Lawmakers Approve Medicaid Payment for Home Births

    Published October 20, 2025
    Publication -
    Minnesota lawmakers approved legislation requiring Medicaid to pay for home births, including paying nurses and midwives the same rate as doctors. The bill, sponsored by a state senator who gave a political speech in 2022 while in labor, was passed as part of a special session agreement with Gov. Tim Walz in June. The legislation […]
  • Trump Takes Steps to Protect Security of U.S. Drug Market

    Published October 15, 2025
    Publication -
    To ensure a “resilient domestic supply chain for essential medicines,” President Trump issued an executive order (EO) directing the Department of Health and Human Services “to develop a list of approximately 26 drugs critical to national health and security.” The August 13 EO also calls for the development of a “repository to receive and maintain […]
  • Pediatric Group Calls for Elimination of Nonmedical Vaccine Exemptions

    Published October 14, 2025
    Publication -
    The American Academy of Pediatrics (AAP) released a report recommending a nationwide ban on nonmedical exemptions from vaccines. The report, published in the August 2025 issue of Pediatrics, argues the geographical clustering of unvaccinated children results in larger communities with “insufficient” vaccination rates for disease prevention, causing “greater likelihood of disease outbreaks.” In states where […]
  • Judge Blocks Use of Medicaid Data for Immigration Enforcement

    Published October 13, 2025
    Publication -
    A federal judge has ordered the U.S. Department of Health and Human Services (HHS) to stop sharing Medicaid data with Immigration and Customs Enforcement (ICE). HHS began sharing Medicaid data in June 2025. On July 4, President Donald Trump signed the One Big Beautiful Bill Act, which stops federal funds intended for law-abiding Americans from […]
  • Expanding Medicaid Hasn’t Improved Health Care – Commentary

    Published October 10, 2025
    Publication -
    The media are clamoring over the Congressional Budget Office’s estimate that 16 million people will lose health insurance by 2034 because of the Trump administration’s policies—10.9 million due to the One Big Beautiful Bill Act alone. Most of the news coverage misses three important details. While it’s true that many people will lose insurance, that […]
  • Mandatory Charity Care Is Unconstitutional Taking of Property, Hospitals

    Published October 3, 2025
    Publication -
    Several hospital systems are considering an appeal to the U.S. Supreme Court after the New Jersey Supreme Court rejected their claim that inadequate compensation for charity care was an unconstitutional taking of private property without just compensation. New Jersey’s charity care program prohibits hospitals from billing patients who qualify for charity care, which the state […]
  • Democrats Fight to Extend Obamacare Costly Middle-Class Subsidies – Commentary

    Published October 2, 2025
    Publication -
    Democrats in Congress are desperately trying to keep Obamacare on life support. The latest scare tactic is from the Kaiser Family Foundation (KFF), which estimates that Obamacare premiums will rise 114 percent without extending the so-called enhanced subsidies. The following is from a CNBC article: “In 2021, the American Rescue Plan Act, a pandemic relief law, temporarily […]
  • Urban Hospitals Pose as Rural for Federal Money, Study Finds

    Published October 2, 2025
    Publication -
    A growing number of urban hospitals are reclassifying themselves as both urban and rural to reap financial benefits Congress intended for rural hospitals only, a new study has found. “In 2016, in response to two federal court decisions, the Centers for Medicare and Medicaid Services began allowing geographically urban hospitals to be dually classified as […]
  • HHS Reinstates Child Vaccine Task Force

    Published October 1, 2025
    Publication -
    The U.S. Department of Health and Human Services (HHS) reinstated a federal task force on pediatric vaccine safety after a hiatus of nearly 30 years. National Institutes of Health (NIH) Director Jay Bhattacharya, M.D., will chair the reinstated task force alongside senior members of the NIH, the Food and Drug Administration (FDA), and the Centers […]
  • Trump Takes Steps to Protect Security of U.S. Drug Market

    Published September 29, 2025
    Publication -
    To ensure a “resilient domestic supply chain for essential medicines,” President Trump issued an executive order (EO) directing the Department of Health and Human Services “to develop a list of approximately 26 drugs critical to national health and security.” The August 13 EO also calls for the development of a “repository to receive and maintain […]
  • Kennedy Shakes Up CDC Leadership Over Vaccine Safety, Efficacy Proof

    Published September 29, 2025
    Publication -
    Major changes are underway at the Centers for Disease Control and Prevention (CDC) following President Trump’s and Health and Human Services (HHS) Secretary Robert Kennedy Jr.’s dismissal of director Susan Monarez and the subsequent resignations of four senior officials in protest over the removal of Monarez. Resigning were the chief medical officer and deputy director […]
  • FDA Halts, Then Resumes Gene Therapy After Three Deaths

    Published September 26, 2025
    Publication -
    After the deaths of three patients, the maker of an investigational gene therapy stopped shipments of the drug after it refused a request from the U.S. Food and Drug Administration (FDA) to pull the drug from the market. Elevidys, made by Sarepta Therapeutics, is the first gene therapy treatment for Duchenne muscular dystrophy (DMD). The […]
  • mRNA vaccine image

    Kennedy Cancels $500 million in mRNA Contracts

    Published September 25, 2025
    Publication -
    The Biomedical Advanced Research and Development Authority (BARDA) is canceling $500 million of contracts to develop mRNA vaccines for flu and COVID, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced. “We reviewed the science, listened to the experts,” said Kennedy in announcing the decision. “BARDA is terminating 22 mRNA vaccine development investments […]
  • Ken Paxton Gage Skidmore

    Texas Attorney General Accuses Drug Company of Kickbacks

    Published September 23, 2025
    Publication -
    Texas Attorney General Ken Paxton filed a civil lawsuit against pharmaceutical giant Eli Lilly, alleging the company illegally induced medical providers to prescribe some of its most profitable drugs, including high-demand GLP-1 weight-loss drugs Mounjaro and Zepbound. The suit alleges violations of the Texas Health Care Program Fraud Prevention Act. The law sets forth thirteen […]

Heartland Newsletters

The Heartland Institute offers free email subscriptions to all of its newsletters and monthly public policy newspapers.